Dark

Check out our API

IIN
IntriCon Corporation
stock NASDAQ

Inactive

May 24, 2022

24.24USD+0.041%(+0.01)94,327

Pre-market

0.00USD-100.000%(-24.23)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Nov 9, 2021

11:16AM EST Recap: IntriCon Q3 Earnings Benzinga

11:14AM EST IntriCon Raises Lower End Of FY21 Sales Guidance From $121M-$125M To $123M-$125M Vs. $124.11M Est. Benzinga

11:13AM EST IntriCon Q3 EPS $0.17 Beats $0.03 Estimate, Sales $31.05M Beat $30.30M Estimate Benzinga

Nov 8, 2021

04:05PM EST Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its third quarter ended September 30, 2021. GlobeNewswire Inc

05:06AM EST Earnings Scheduled For November 8, 2021 Benzinga

Oct 29, 2021

04:06PM EDT IntriCon Sees Q3 2021 Revs ~$31.1M Benzinga

04:05PM EDT Intricon Announces Departure Of CFO Benzinga

04:05PM EDT Intricon Announces CFO Departure and Preliminary Third Quarter GlobeNewswire Inc

Oct 25, 2021

04:05PM EDT Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2021 third quarter results on Monday, November 8, 2021, after market close. GlobeNewswire Inc

Oct 20, 2021

04:05PM EDT OTC Hearing Aid Act designed to offer greater public access to hearing aids at a lower costIntricon well positioned to provide the ecosystem necessary to deliver high customer satisfaction GlobeNewswire Inc

Sep 30, 2021

04:06PM EDT Intricon Announces Summative Usability Validation Has Been Completed In Over-The-Counter Hearing Aids Benzinga

04:05PM EDT Intricon Corporation(NASDAQ: IIN), a joint development manufacturer of micromedical technology for use in interventional, implantable, and body-worn medical devices, announced that it has achieved a critical milestone in the clinical study of its proprietary software that will allow people to self-fit hearing aids that are sold over-the-counter at retail stores and online. GlobeNewswire Inc

Aug 9, 2021

05:19PM EDT Intricon Raises FY21 Sales Guidance From $119M-$123M To $121M-$125M vs $121.02M Est. Benzinga

05:18PM EDT IntriCon Q2 EPS $(0.13) Misses $0.08 Estimate, Sales $30.20M Beat $28.56M Estimate Benzinga

04:06PM EDT Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its second quarter ended June 30, 2021. GlobeNewswire Inc

08:00AM EDT Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering, and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that David Liebl has joined the company as Vice President of R&D, effective today. GlobeNewswire Inc

04:11AM EDT Earnings Scheduled For August 9, 2021 Benzinga

Jul 26, 2021

04:05PM EDT Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2021 second quarter results on Monday, August 9, 2021, after market close. GlobeNewswire Inc

May 10, 2021

04:34PM EDT IntriCon Sees FY21 Sales $119M-$123M Vs $117.35M Estimates Benzinga

04:33PM EDT IntriCon Q1 EPS $0.26 Up From $(0.08) YoY, Sales $31.80M Beat $26.75 Estimate Benzinga

04:05PM EDT Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its first quarter ended March 31, 2021. GlobeNewswire Inc

04:09AM EDT Earnings Scheduled For May 10, 2021 Benzinga

Apr 26, 2021

04:05PM EDT Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2021 first quarter results on Monday, May 10, 2021, after market close. GlobeNewswire Inc

Feb 25, 2021

05:01PM EST IntriCon Q4 EPS $0.12 Beats $0.04 Estimate, Sales $30.30M Beat $27.35M Estimate Benzinga

04:37PM EST IntriCon: Q4 Earnings Insights Benzinga

04:03AM EST Earnings Scheduled For February 25, 2021 Benzinga

Feb 11, 2021

04:05PM EST Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2020 fourth quarter and full year results on Thursday, February 25, 2021, after market close. GlobeNewswire Inc

Feb 8, 2021

04:13PM EST Intricon Corp Announces That Ellen Scipta Was Appointed As CFO Benzinga

04:05PM EST Intricon Corporation Announces Appointment of Chief Financial Officer GlobeNewswire Inc

Nov 9, 2020

04:16PM EST IntriCon Q3 EPS $0.07 Beats $0.05 Estimate, Sales $27.40M Beat $24.54M Estimate Benzinga

04:05PM EST Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced financial results for its third quarter ended September 30, 2020. GlobeNewswire Inc

04:13AM EST Earnings Scheduled For November 9, 2020 Benzinga

Nov 6, 2020

10:20AM EST A Preview Of IntriCon's Earnings Benzinga

Nov 4, 2020

04:05PM EST IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of body-worn devices, today announced that Scott Longval, IntriCons President and Chief Executive Officer will present at the upcoming Virtual 2020 Stifel Healthcare Conference. GlobeNewswire Inc

Oct 26, 2020

04:05PM EDT IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2020 third-quarter results on Monday, November 9, 2020, at market close. GlobeNewswire Inc

Aug 10, 2020

04:16PM EDT IntriCon Q2 EPS $(0.26) Beats $(0.29) Estimate, Sales $23.60M Beat $20.15M Estimate Benzinga

04:05PM EDT IntriCon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced financial results for its second quarter ended June 30, 2020. GlobeNewswire Inc

04:10AM EDT Earnings Scheduled For August 10, 2020 Benzinga

Jul 27, 2020

04:05PM EDT IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2020 second-quarter results on Monday, August 10, 2020, at market close. GlobeNewswire Inc

Share